Minimally Invasive Surgical Instruments Market worth $49.9 billion by 2029
The report "Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestional, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029", is projected to reach USD 49.9 billion by 2029 from USD 31.7 billion in 2024, at a CAGR of 9.5% during the forecast period.
Browse 450 market data Tables and 54 Figures spread through 409 Pages and in-depth TOC on "Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestional, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-surgical-instruments-devices-market-682.html
The growth of the market is fueled by several factors, notably the escalating number of surgical procedures conducted worldwide. Additionally, the increasing adoption of minimally invasive surgical procedures is contributing significantly. These procedures offer various advantages such as reduced postoperative pain, shorter hospital stays, quicker recovery times, and lower risk of complications compared to traditional open surgeries.
“The handheld instruments segment accounted for the largest share of the minimally invasive surgical instruments market, by product segment”
By product, the market is primarily segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, robotic instruments and other instruments. The minimally invasive surgical instruments market in 2023 was predominantly led by the handheld instruments segment. The expansion of the handheld instruments segment is driven by the affordability of articulating laparoscopic handheld surgical instruments. These versatile tools find widespread application in various surgical procedures including cardiothoracic, arthroscopy, urology, cardiovascular, and neurological surgeries.
“The robotic surgery segment accounted for the highest growth in the minimally invasive surgical instruments market”
By technology, the market is primarily segmented into non-robotic surgery and robotic surgery. In 2023, robotic surgery accounted for the highest growth rate. The growth rate of this segment is high due to the precision and dexterity offered by robotic systems enable surgeons to perform complex procedures with enhanced accuracy, leading to improved patient outcomes and reduced postoperative complications. Additionally, MIS robotic surgery allows for smaller incisions, resulting in less tissue trauma, reduced blood loss, and faster recovery times compared to traditional open surgery methods.
“The cardiothoracic segment held the topmost market share in the minimally invasive surgical instruments market”
By Type of Surgery, the market is primarily segmented into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries.In the MIS instruments market, the cardiothoracic segment held the most significant share in 2023 reason being advancements in surgical techniques and technology have enabled cardiothoracic surgeons to perform complex procedures with minimally invasive approaches, resulting in reduced trauma, shorter hospital stays, and faster recovery times for patients. Additionally, there is a growing preference for MIS among patients due to its perceived benefits, leading to increased demand for these procedures.
“Hospitals and specialty clinics segment accounted for the highest share”
By end user, the market is primarily segmented into hospitals and specialty clinics and ambulatory surgery centers. The hospitals and specialty clinics segment accounted for a larger share of the minimally invasive surgical instruments market in 2023. Hospitals and specialty clinics allocate greater investments towards lab automation and information management compared to other end users. They possess advanced capabilities to conduct numerous tests efficiently. Due to these advantages, countries like India and China are prioritizing the expansion of hospitals within their healthcare systems. Consequently, the adoption of minimally invasive surgical instruments is more prevalent in hospitals and specialty clinics.
“North America aimed for the largest share of the minimally invasive surgical instruments market”.
The global minimally invasive surgical instruments market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa and GCC Countries. North America is the largest regional market for genotyping assays. North America is the largest regional market for minimally invasive surgical instruments. The presence of leading companies like Medtronic plc, Johnson & Johnson, Stryker Corporation, and Abbott Laboratories, Inc. within this region contributes to the advancement of the minimally invasive surgical instruments market.
The major players leading in this market are Medtronic PLC (US), Johnson & Johnson (US), Intuitive Surgical Inc. (US), Boston Scientific Corporation (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), B. Braun SE (Germany), Conmed Corporation (US), Smith + Nephew (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Company (US), The Cooper Companies Inc. (US), Surgical Innovations Group PLC(UK), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation(Japan).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Minimally Invasive Surgical Instruments Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
